Compounds > cilostazol

cilostazol and arachidonic acid

cilostazol has been researched along with arachidonic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, Y; Nakase, H; Watanabe, K1
Fukuda, Y; Fukuta, Y; Higashino, R; Ito, S; Kurimoto, T; Suzuki, Y; Takei, M; Tamaki, H; Tanaka, T1
Arima, J; Ayukawa, O; Iguro, Y; Kariyazono, H; Majima, HJ; Masuda, H; Nakamura, K; Onimaru, S; Sakata, R; Yamada, K1
Fukasawa, I; Inoue, O; Kanemaru, K; Kimura, Y; Kinouchi, H; Ohta, M; Ozaki, Y; Satoh, K; Yoda, S1
Hashimoto, A; Ito, H; Nagano, K; Takeda, S; Tanaka, M1

Other Studies

5 other study(ies) available for cilostazol and arachidonic acid

ArticleYear
Effect of cilostazol on experimental cerebral infarction in rabbits.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:7

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Azoles; Brain; Cerebral Infarction; Cilostazol; Injections, Intravenous; Piperidines; Rabbits; Tetrazoles; Vasodilator Agents

1986
Z-335, a thromboxane A2 receptor antagonist, suppresses the progression of arachidonic acid-induced hind limb gangrene in rats.
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:12

    Topics: Animals; Arachidonic Acid; Cilostazol; Fibrinolytic Agents; Gangrene; Hindlimb; Indans; Leg Injuries; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Tetrazoles

1999
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Carbazoles; Cilostazol; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Humans; Microscopy, Confocal; Phosphodiesterase Inhibitors; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Reproducibility of Results; Sulfonamides; Tetrazoles

2004
Platelet aggregometry in the presence of PGE(1) provides a reliable method for cilostazol monitoring.
    Thrombosis research, 2012, Volume: 130, Issue:4

    Topics: Aged; Alprostadil; Arachidonic Acid; Blood Platelets; Cilostazol; Drug Monitoring; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Sensitivity and Specificity; Tetrazoles

2012
Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLCĪµ and to Activate p44/42 MAPK in Human Aortic Endothelial Cells.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Aorta; Arachidonic Acid; Calcium; Cell Line; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelial Cells; Epoprostenol; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Humans; Inositol 1,4,5-Trisphosphate Receptors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Phosphodiesterase 3 Inhibitors; Phosphoinositide Phospholipase C; RNA, Small Interfering; Shelterin Complex; Signal Transduction; Telomere-Binding Proteins; Tetrazoles

2015